The significance of BAFF and APRIL, and their receptors BCMA and TACI, in the growth and survival of myeloma cells suggests that these paired ligands and receptors can be targets for the development of new therapies against MM. The gene discussed is TNFSF13; the disease is plasma cell myeloma.